全文获取类型
收费全文 | 47168篇 |
免费 | 2818篇 |
国内免费 | 97篇 |
专业分类
耳鼻咽喉 | 685篇 |
儿科学 | 2481篇 |
妇产科学 | 1256篇 |
基础医学 | 5309篇 |
口腔科学 | 2008篇 |
临床医学 | 4238篇 |
内科学 | 10070篇 |
皮肤病学 | 1202篇 |
神经病学 | 3866篇 |
特种医学 | 1490篇 |
外国民族医学 | 5篇 |
外科学 | 7077篇 |
综合类 | 402篇 |
一般理论 | 19篇 |
预防医学 | 3035篇 |
眼科学 | 1130篇 |
药学 | 2976篇 |
中国医学 | 220篇 |
肿瘤学 | 2614篇 |
出版年
2024年 | 39篇 |
2023年 | 391篇 |
2022年 | 275篇 |
2021年 | 797篇 |
2020年 | 537篇 |
2019年 | 802篇 |
2018年 | 1487篇 |
2017年 | 1083篇 |
2016年 | 1141篇 |
2015年 | 1009篇 |
2014年 | 1133篇 |
2013年 | 2060篇 |
2012年 | 3422篇 |
2011年 | 4023篇 |
2010年 | 1725篇 |
2009年 | 1076篇 |
2008年 | 3352篇 |
2007年 | 3661篇 |
2006年 | 3479篇 |
2005年 | 3543篇 |
2004年 | 3426篇 |
2003年 | 3204篇 |
2002年 | 2966篇 |
2001年 | 1133篇 |
2000年 | 1060篇 |
1999年 | 642篇 |
1998年 | 367篇 |
1997年 | 234篇 |
1996年 | 225篇 |
1995年 | 184篇 |
1994年 | 158篇 |
1993年 | 138篇 |
1992年 | 126篇 |
1991年 | 110篇 |
1990年 | 107篇 |
1989年 | 80篇 |
1988年 | 78篇 |
1987年 | 76篇 |
1986年 | 63篇 |
1985年 | 58篇 |
1984年 | 61篇 |
1983年 | 52篇 |
1982年 | 58篇 |
1981年 | 52篇 |
1980年 | 43篇 |
1979年 | 41篇 |
1978年 | 37篇 |
1977年 | 41篇 |
1976年 | 23篇 |
1973年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Human plectin: organization of the gene, sequence analysis, and chromosome localization (8q24). 总被引:14,自引:0,他引:14
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
C G Liu C Maercker M J Casta?on R Hauptmann G Wiche 《Proceedings of the National Academy of Sciences of the United States of America》1996,93(9):4278-4283
Plectin, a 500-kDa intermediate filament binding protein, has been proposed to provide mechanical strength to cells and tissues by acting as a cross-linking element of the cytoskeleton. To set the basis for future studies on gene regulation, tissue-specific expression, and pathological conditions involving this protein, we have cloned the human plectin gene, determined its coding sequence, and established its genomic organization. The coding sequence contains 32 exons that extend over 32 kb of the human genome. Most of the introns reside within a region encoding the globular N-terminal domain of the molecule, whereas the entire central rod domain and the entire C-terminal globular domain were found to be encoded by single exons of remarkable length, >3 kb and >6 kb, respectively. Overall, the organization of the human plectin gene was strikingly similar to that of human bullous pemphigoid antigen 1 (BPAG1), confirming that both proteins belong to the same gene family. Comparison of the deduced protein sequences for human and rat plectin revealed that they were 93% identical. By using fluorescence in situ hybridization, we have mapped the plectin gene to the long arm of chromosome 8 within the telomeric region. This gene locus (8q24) has previously been implicated in the human blistering skin disease epidermolysis bullosa simplex Ogna. Detailed knowledge of the structure of the plectin gene and its chromosome localization will aid in the elucidation of whether this or any other pathological conditions are linked to alterations in the plectin gene. 相似文献
992.
993.
Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
de Goër de Herve MG Durali D Tran TA Maigné G Simonetta F Leclerc P Delfraissy JF Taoufik Y 《Blood》2005,106(8):2806-2814
Agonistic monoclonal antibodies to CD40 (CD40 mAbs) have a puzzling dual therapeutic effect in experimental animal models. CD40 mAbs induce tumor regression by potentiating antitumoral T-cell responses, yet they also have immunosuppressive activity in chronic autoimmune inflammatory processes. CD40 mAbs are thought to act on antigen presentation by dendritic cells (DCs) to T cells. DCs can be distinguished as either immature or mature by their phenotype and their ability to generate an effective T-cell response. Here we found that, on human cells, although anti-CD40 led immature DCs to mature and became immunogenic, it also reduced the capacity of lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNF-alpha)-matured DCs to generate a specific CD4 T-cell response. This inhibitory effect was related to rapid and selective apoptosis of mature DCs. Anti-CD40-mediated apoptosis was due to an indirect mechanism involving cooperation with the death domain-associated receptor Fas, leading to activation of Fas-associated death domain protein (FADD) and caspase-8. On human cells, CD40 activation by such agonists could, therefore, trigger immune responses to antigens presented by immature DCs, which are otherwise nonimmunogenic, by inducing maturation. On the other hand, anti-CD40 mAbs, by rapidly inducing apoptosis, may reduce the capacity of inflammatory signal-matured immunogenic DCs to generate an effective T-cell response. These results call for caution in CD40 mAb-based immunotherapy strategies. 相似文献
994.
Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity 总被引:18,自引:4,他引:18
Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons (IFNs) upon exposure to enveloped viruses. However, their role in adaptive immune responses, such as the initiation of antiviral T-cell responses, is not known. In this study, we examined interactions between blood pDCs and influenza virus with special attention to the capacity of pDCs to activate influenza-specific T cells. pDCs were compared with CD11c(+) DCs, the most potent antigen-presenting cells (APCs), for their capacity to activate T-cell responses. We found that like CD11c(+) DCs, pDCs mature following exposure to influenza virus, express CCR7, and produce proinflammatory chemokines, but differ in that they produce type I IFN and are resistant to the cytopathic effect of the infection. After influenza virus exposure, both DC types exhibited an equivalent efficiency to expand anti-influenza virus cytotoxic T lymphocytes (CTLs) and T helper 1 (TH1) CD4(+) T cells. Our results pinpoint a new role of pDCs in the induction of antiviral T-cell responses and suggest that these DCs play a prominent role in the adaptive immune response against viruses. 相似文献
995.
Maron BJ McKenna WJ Danielson GK Kappenberger LJ Kuhn HJ Seidman CE Shah PM Spencer WH Spirito P Ten Cate FJ Wigle ED;Task Force on Clinical Expert Consensus Documents. American College of Cardiology;Committee for Practice Guidelines. European Society of Cardiology 《Journal of the American College of Cardiology》2003,42(9):1687-1713
996.
Ventilator-associated pneumonia 总被引:61,自引:0,他引:61
Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of patients receiving mechanical ventilation (MV). In contrast to infections of more frequently involved organs (e.g., urinary tract and skin), for which mortality is low, ranging from 1 to 4%, the mortality rate for VAP ranges from 24 to 50% and can reach 76% in some specific settings or when lung infection is caused by high-risk pathogens. The predominant organisms responsible for infection are Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae, but etiologic agents widely differ according to the population of patients in an intensive care unit, duration of hospital stay, and prior antimicrobial therapy. Because appropriate antimicrobial treatment of patients with VAP significantly improves outcome, more rapid identification of infected patients and accurate selection of antimicrobial agents represent important clinical goals. Our personal bias is that using bronchoscopic techniques to obtain protected brush and bronchoalveolar lavage specimens from the affected area in the lung permits physicians to devise a therapeutic strategy that is superior to one based only on clinical evaluation. When fiberoptic bronchoscopy is not available to physicians treating patients clinically suspected of having VAP, we recommend using either a simplified nonbronchoscopic diagnostic procedure or following a strategy in which decisions regarding antibiotic therapy are based on a clinical score constructed from seven variables. Selection of the initial antimicrobial therapy should be based on predominant flora responsible for VAP at each institution, clinical setting, information provided by direct examination of pulmonary secretions, and intrinsic antibacterial activities of antimicrobial agents and their pharmacokinetic characteristics. Further trials will be needed to clarify the optimal duration of treatment and the circumstances in which monotherapy can be safely used. 相似文献
997.
Lapierre V Aupérin A Tayebi H Chabod J Saas P Michalet M François S Garban F Giraud C Tramalloni D Oubouzar N Blaise D Kuentz M Robinet E Tiberghien P;Société Française de Greffe de Moelle et de Thérapiue Cellulaire 《Blood》2002,100(4):1484-1489
We have recently shown that the use of allogeneic granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood hematopoietic stem cell transplantation (PBHSCT), as compared with bone marrow transplantation (BMT), is associated with increased titers of antibodies (Abs) directed against red blood cell ABO antigens. To further evaluate the influence of a G-CSF-mobilized PBHSCT graft on alloimmune Ab responses, we examined the frequency of anti-HLA Abs after transplantation in the setting of the same randomized study, comparing PBHSCT with BMT in adults. Anti-HLA Ab presence was determined by complement-dependent cytotoxicity assay (CDC) and flow cytometry in the recipient before and 30 days after transplantation as well as in the donor before graft donation. The use of PBHSCT was significantly associated with increased detection of anti-HLA immunoglobulin G (IgG) Abs early after transplantation as evidenced by flow cytometry (11 of 24 versus 4 of 27 transplant recipients, P =.03) and, less so, by CDC (5 of 24 versus 1 of 27 transplant recipients, P =.09). The difference between PBHSCT and BMT was further heightened when analysis was restricted to anti-HLA IgG Ab-negative donor/recipient pairs. In such a setting, early anti-HLA Ab was never detected after BMT but was repeatedly detected after PBHSCT (flow cytometry, 6 of 18 versus 0 of 17 transplant recipients, P =.02; CDC, 4 of 23 versus 0 of 26 transplant recipients, P =.04). Importantly, the PBHSCT-associated increase in anti-HLA Ab detection was observed despite a reduction in the median number of platelet-transfusion episodes per patient in PBHSC transplant versus BM transplant recipients (3 platelet-transfusion episodes [range, 1-21] in PBHSCT group vs 6 platelet-transfusion episodes [range, 3-33] in the BMT group; P =.02). In conclusion, this study strongly suggests that G-CSF-mobilized PBHSCT results in an increased incidence of circulating anti-HLA Abs and further confirms that the use of such a graft alters alloimmune Ab responses. 相似文献
998.
Fantoni C Regoli F Ghanem A Raffa S Klersy C Sorgente A Faletra F Baravelli M Inglese L Salerno-Uriarte JA Klein HU Moccetti T Auricchio A 《European journal of heart failure》2008,10(3):298-307
BACKGROUND: Diabetes mellitus is an independent risk factor for increased morbidity and mortality in heart failure (HF) patients. AIMS: To compare functional and structural improvement, as well as long-term outcome, between diabetic and non-diabetic HF patients treated with cardiac resynchronization therapy (CRT). METHODS: We compared response to CRT in 141 diabetic and 214 non-diabetic consecutive patients. Major events were; death from any cause, urgent heart transplantation and implantation of a left ventricular (LV) assist device. Frequencies of hospitalisation and defibrillator (CRT-D) discharges were also analyzed. RESULTS: CRT was able to significantly improve functional capacity, ventricular geometry and neurohumoral imbalance in both diabetic and non-diabetic patients over a median follow-up time of 34 months. Overall event-free survival was similar in diabetic and non-diabetic patients (HR 1.23, p=0.363), as was survival free from CRT-D interventions (HR 1.72; p=0.115) and hospitalisations (HR 1.12; p=0.500). On multivariable analysis, NYHA class IV (p=0.002), low LV ejection fraction (p=0.002), absence of beta-blocker therapy (p<0.001), impaired renal function (p=0.003), presence of an epicardial lead (p=0.025), but not diabetes (p=0.821) were associated with a poor outcome after CRT. CONCLUSIONS: Diabetic HF patients treated with CRT had a very favourable functional and survival outcome, which was comparable to non-diabetic patients. 相似文献
999.
OBJECTIVE: To determine the yield of contact tracing after exposure to active tuberculosis (TB) cases in a low incidence area for TB as well as completion rate and tolerance to treatment for latent TB infection (LTBI). METHODS: Retrospective study based on a database including all patients evaluated in Geneva during contact tracing procedures; review of medical records of contacts for whom treatment of LTBI was indicated. RESULTS: 3582 subjects were screened over 10 years (on average 4.3 contacts per index case); 8 (0.2%) had active TB. LTBI was detected in 28% of subjects screened. Foreign origin, exposure and contagiousness of index case were predictive of LTBI. Of the 996 subjects with LTBI, files of 705 subjects followed at our centre were reviewed: treatment was indicated in 571 (81%). Side-effects led to interruption of treatment for LTBI in 32 cases (6.9% of subjects treated); 227 subjects eligible for treatment (40%) either refused or stopped treatment, or were lost to follow-up. Completion rate was 67%. CONCLUSIONS: In a low-incidence environment for TB, contact tracing procedures had a very low yield for detection of active TB cases; acceptance and completion rates for LTBI therapy were in agreement with recent studies.. 相似文献
1000.
Eliano P. Navarese MD PhD Lara Frediani MD David E. Kandzari MD Gianluca Caiazzo MD Angela Marella Cenname MD Bernardo Cortese MD PhD MD Tommaso Piva MD Andi Muçaj MD Carlo Tumscitz MD Francesco Paparoni MD Claudio Larosa MD Teodoro Bisceglia MD Mila Menozzi MD Paul A. Gurbel MD Jacek Kubica MD PhD 《Catheterization and cardiovascular interventions》2021,97(4):602-611